Search Results - "therapy [Medulloblastoma]"

Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa—Results of the HIT 2000 trial

Authors: Martin Mynarek Anne Rossius Anika Guiard et al.

Source: Neuro-Oncology 26(11), 2113-2124 (2024). doi:10.1093/neuonc/noae092
Mynarek, M, Rossius, A, Guiard, A, Ottensmeier, H, von Hoff, K, Obrecht-Sturm, D, Bußenius, L, Friedrich, C, von Bueren, A O, Gerber, N U, Traunwieser, T, Kortmann, R-D, Warmuth-Metz, M, Bison, B, Thomale, U-W, Krauss, J, Pietsch, T, Clifford, S C, Pfister, S M, Sturm, D, Sahm, F, Tischler, T & Rutkowski, S 2024, ' Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa-Results of the HIT 2000 trial ', Neuro-Oncology . https://doi.org/10.1093/neuonc/noae092

Subject Terms: Male, Mutism / etiology, quality of survival, ependymoma, Adolescent, Mutism, Cancer Survivors / psychology, etiology [Hydrocephalus], etiology [Mutism], Infratentorial Neoplasms, Neuropsychological Tests, Cognition Disorders / etiology, medulloblastoma, Cancer Survivors, Risk Factors, Infratentorial Neoplasms / therapy, Humans, ddc:610, Child, statistics & numerical data [Cancer Survivors], Ependymoma / therapy, 2. Zero hunger, neuropsychological late effects, Infant, etiology [Cognition Disorders], Neuropsychological late effects, Hydrocephalus / etiology, therapy [Medulloblastoma], Prognosis, Quality of survival, infant, 3. Good health, Ependymoma, Child, Preschool, therapy [Infratentorial Neoplasms], psychology [Cancer Survivors], Medulloblastoma / therapy, Female, Cancer Survivors / statistics & numerical data, Cognition Disorders, therapy [Ependymoma], Medulloblastoma, Follow-Up Studies, Hydrocephalus

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/38835160

Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies

Authors: Obrecht, Denise Mynarek, Martin Hagel, Christian et al.

Contributors: Obrecht, Denise Mynarek, Martin Hagel, Christian et al.

Source: J Neurooncol
Journal of neuro-oncology 157(1), 37-48 (2022). doi:10.1007/s11060-021-03913-5

Subject Terms: Cerebellar Neoplasms / drug therapy, therapy [Cerebellar Neoplasms], Medizin, Medulloblastoma / drug therapy, 610 Medicine & health, Cerebellar Neoplasms / therapy, Metastases, 03 medical and health sciences, 0302 clinical medicine, Craniospinal Irradiation, Risk Factors, drug therapy [Cerebellar Neoplasms], Humans, 1306 Cancer Research, ddc:610, drug therapy [Medulloblastoma], Cerebellar Neoplasms, Child, Children, Radiotherapy, therapy [Medulloblastoma], 3. Good health, 2728 Neurology (clinical), Cerebrospinal fluid, 10036 Medical Clinic, 2808 Neurology, Clinical Study, 2730 Oncology, Medulloblastoma / therapy, Medulloblastoma

File Description: application/pdf; ZORA_228196.pdf - application/pdf

Access URL: https://link.springer.com/content/pdf/10.1007/s11060-021-03913-5.pdf
https://pubmed.ncbi.nlm.nih.gov/35190934
https://pub.dzne.de/record/163608
https://archive-ouverte.unige.ch/unige:174529
https://doi.org/10.1007/s11060-021-03913-5
https://nbn-resolving.org/urn:nbn:de:bvb:384-opus4-943889
https://doi.org/10.1007/s11060-021-03913-5
https://opus.bibliothek.uni-augsburg.de/opus4/files/94388/Obrecht2022_Article_ClinicalAndMolecularCharacteri.pdf
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/94388
https://www.zora.uzh.ch/id/eprint/228196/
https://doi.org/10.5167/uzh-228196
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85124902150
https://doi.org/10.1007/s11060-021-03913-5
https://www.ncbi.nlm.nih.gov/pubmed/35190934

Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort

Authors: Andrey Golanov Katharina Filipski Andreas Faldum et al.

Contributors: Andrey Golanov Katharina Filipski Andreas Faldum et al.

Source: Journal of clinical oncology 38(18), 2028-2040 (2020). doi:10.1200/JCO.19.03057
Journal of clinical oncology, Vol. 38, No 18 (2020) pp. 2028-2040

Subject Terms: Male, 0301 basic medicine, Cerebellar Neoplasms / drug therapy, Cerebellar Neoplasms / radiotherapy, Medizin, Medulloblastoma / drug therapy, radiotherapy [Medulloblastoma], Neuropsychological Tests, adverse effects [Cranial Irradiation], administration & dosage [Methotrexate], 03 medical and health sciences, 0302 clinical medicine, mortality [Cerebellar Neoplasms], drug therapy [Cerebellar Neoplasms], Humans, ddc:610, drug therapy [Medulloblastoma], Prospective Studies, Cerebellar Neoplasms, ddc:618, Cranial Irradiation / adverse effects, Cerebellar Neoplasms / mortality, Infant, Methotrexate / administration & dosage, DNA Methylation, 3. Good health, Methotrexate, Medulloblastoma / radiotherapy, Child, Preschool, Medulloblastoma / mortality, Female, radiotherapy [Cerebellar Neoplasms], Cranial Irradiation, mortality [Medulloblastoma], Medulloblastoma

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/32330099
https://ascopubs.org/doi/pdf/10.1200/JCO.19.03057
https://www.zora.uzh.ch/id/eprint/197967/
http://www.ncbi.nlm.nih.gov/pubmed/32330099
https://pubmed.ncbi.nlm.nih.gov/32330099/
https://ascopubs.org/doi/10.1200/JCO.19.03057
https://www.ncbi.nlm.nih.gov/pubmed/32330099
https://pub.dzne.de/record/153356
https://archive-ouverte.unige.ch/unige:157305
https://resolver.sub.uni-goettingen.de/purl?gro-2/81566
https://www.ncbi.nlm.nih.gov/pubmed/32330099
https://doi.org/10.1200/JCO.19.03057
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85086747000